F. Stephen Hodi, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma (NCT04356729) | F. Stephen Hodi, MD | 2020-08-06 |
| Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma (NCT02141542) | F. Stephen Hodi, MD | 2014-05-01 |
Track F. Stephen Hodi, MD automatically
Every clearance here is in the API, with alerts when new ones post.